Article metrics

Download PDFPDF
Prognostic Value of Human Epidermal Growth Factor Receptor 2 (Her-2)/neu in Patients With Advanced Ovarian Cancer Treated With Platinum/Paclitaxel as First-Line Chemotherapy: A Retrospective Evaluation of the AGO-OVAR 3 Trial by the AGO OVAR Germany

 

Online download statistics by month:

Online download statistics by month: March 2019 to January 2023

AbstractFullPdf
Mar 20191400
Apr 20191700
May 20192000
Jun 20191400
Jul 20193300
Aug 20191801
Sep 20191400
Oct 20191400
Nov 20191601
Dec 20192200
Jan 20201200
Feb 20201700
Mar 20201400
Apr 20201400
May 20202201
Jun 20201800
Jul 20201000
Aug 2020800
Sep 2020800
Oct 2020800
Nov 2020400
Dec 2020600
Jan 20211400
Feb 20212000
Mar 20211800
Apr 2021800
May 2021200
Oct 20211700
Nov 2021600
Dec 20211400
Jan 20226400
Feb 20222500
Mar 20223000
Apr 20222200
May 20224500
Jun 20224602
Jul 20223200
Aug 20225200
Sep 20226203
Oct 20225200
Nov 20221600
Dec 20223600
Jan 20232200
Total92608